Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial

Benjamin Z. Leder(Massachusetts General Hospital), Sherri‐Ann M. Burnett‐Bowie(Massachusetts General Hospital), Alexander V. Uihlein(Harvard University), Paul Wallace(Harvard University), Hang Lee(Massachusetts General Hospital), Robert M. Neer(Brigham and Women's Hospital), Joy N. Tsai(Harvard University)
The Lancet
July 4, 2015
Cited by 574


Related Papers